CAPITOL HILL STRATEGIES, LLC for BIOGEN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 9, Innovation Act (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act S.632, Support Technology and Research for Our Nation's Growth Patents Act of 2015(BPCIA)).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner,LD-CongMcIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Medical/Disease Research/Clinical Labs MED
S. 320, The Medical Innovation Act. Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research. H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner,LD-CongMcIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.